PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • PDR Drug Communications are designed to improve the speed and efficacy of the delivery of PDR Drug Alerts, Recalls and Approvals to physicians, prescribers, and their staff.

    Below are the PDR Drug Communications that have been issued by PDR Network. To view the communication details, click on the Medication name.

    If you have trouble accessing Alert details, click to get the latest version of the free Adobe Acrobat Reader software for your computer.

    Filter results by:

    Results 1-9 of 9

    October 30, 2014 Drug Approval:

    HETLIOZ® (tasimelteon)

    Vanda Pharmaceuticals, Inc.

    March 31, 2014 Drug Approval:

    Aptiom® (eslicarbazepine acetate)

    Sunovion Pharmaceuticals

    February 13, 2014 Drug Approval:

    NEXAVAR® (sorafenib)

    Bayer

    September 10, 2013 Drug Approval:

    Latuda (lurasidone HCl)

    Sunovion Pharmaceuticals

    December 04, 2012 Drug Approval:

    RECTIV® (nitroglycerin)

    Aptalis

    November 20, 2012 Drug Approval:

    Lyrica (pregabalin)

    Pfizer Pharmaceuticals LLC

    June 12, 2012 Drug Approval:

    RECTIV(TM) (nitroglycerin)

    Aptalis

    January 05, 2012 Drug Approval:

    Eylea(TM)

    Regeneron

    Results 1-9 of 9